Vuno gets European CE MDR Certification for AI-Powered Medical Device

Vuno has achieved a milestone by obtaining the European CE MDR certification for its AI-powered electrocardiogram (ECG) medical device, the HATIV P30. This success opens up new markets in Europe by allowing you to sell the device across the European Union (EU).

Understanding CE MDR and HATIV P30 Device

CE MDR stands for European Medical Device Regulation, which you must follow to export medical devices to the EU. It replaces the former Medical Device Directive (MDD) and has been in effect since May 2021.

• Purpose: HATIV P30 evaluates ECG data to determine normal sinus rhythm, atrial fibrillation, bradycardia, and tachycardia.
• Convenience: The device is compact and portable, allowing you to measure heart signals easily within 30 seconds.
• Accessibility: Check analysis results via the ‘HATIV Care’ app on your phone.

Market Expansion Strategy

Vuno plans to expand in Europe through:

1. Engaging in marketing and sales activities.
2. Showcasing clinical efficacy at European conferences and exhibitions.
3. Developing partnerships with distributors and targeting retail and hospital markets.

Other Certifications

Vuno has already received the UKCA (UK Conformity Assessed) certification for the HATIV P30 in the UK.

Future Vision and Developments

Vuno’s CEO, Yea Ha Lee, views the certification as a key step to becoming a leader in AI-based biosignals. The company is:

• Developing the AI software ‘VUNO Med Deep-ECG’ to link with HATIV.
• Planning to help individuals monitor cardiovascular health and seek timely treatment.

Key Takeaways

• CE MDR allows wider access to the European market.
• HATIV P30 offers accurate ECG readings quickly and can be easily operated.
• Vuno aims to secure a strong presence in the biosignal monitoring sector.

If you’re interested in the latest advancements in AI medical devices, Vuno is at the forefront with its innovative ECG solutions.

Table of Contents:

1. Introduction
   • Overview of Vuno’s achievement in obtaining CE MDR certification
   • Importance of this certification for entering the European market
2. Understanding CE MDR and HATIV P30 Device
   • Explanation of CE MDR and its relevance to medical device exports to the EU
   • Description of the HATIV P30 device and its functionality:
     • Purpose of evaluating ECG data for various heart conditions
     • Convenience and portability for quick measurements
     • Accessibility through the ‘HATIV Care’ app
3. Market Expansion Strategy
   • Vuno’s plans to engage in marketing and sales activities in Europe
   • Participation in European conferences and exhibitions to showcase clinical efficacy
   • Development of partnerships with distributors for retail and hospital markets
4. Other Certifications
   • Overview of the UKCA certification received for HATIV P30 in the UK
   • Significance of multiple certifications for market credibility
5. Future Vision and Developments
   • Insights from CEO Yea Ha Lee on the importance of certification for leadership in AI-based biosignals
   • Ongoing development of the AI software ‘VUNO Med Deep-ECG’
   • Goals for improving cardiovascular health monitoring and timely treatment access
6. Key Takeaways
   • Summary of the significance of CE MDR for market access in Europe
   • Advantages of the HATIV P30 in providing accurate and quick ECG readings
   • Vuno’s ambitions for a strong presence in the biosignal monitoring sector
7. Conclusion
   • Final thoughts on Vuno’s innovation in AI medical devices and their impact on health monitoring
   • Encouragement to follow advancements in Vuno’s products and technologies